Bronchogen 20 MG

Broncogen is a synthetic peptide derivative structurally designed for research purposes in models of respiratory health and airway modulation. It has been developed as a stabilized analog and is primarily studied in laboratory settings for its potential effects on bronchial tissue protection, mucosal healing, and peptide pharmacology. Preclinical studies have investigated Broncogen in relation to experimental models of airway inflammation, fibrosis, and mucociliary function.

Research involving Broncogen commonly explores:

• Its role in modulating inflammatory signaling pathways and cytokine profiles in respiratory epithelial and animal models.
• Possible contributions to reduction of bronchial hyperresponsiveness and fibrotic changes in induced airway injury studies.
• Experimental promotion of mucociliary clearance and epithelial repair mechanisms in controlled laboratory systems.
• Its activity in studies of recovery from lung insult, airway remodeling, and long-term mucosal maintenance, where its peptide sequence and stability are topics of interest.
Broncogen is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.

Product details:

• Synonyms: Broncogen peptide
• Purity: ≥98%
• CAS Number: not registered or unavailable
• Molecular Formula: not available
• Molecular Weight: not available
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.